TipRanks
WORK Medical Technology Group LTD (WOK)
NASDAQ:WOK
US Market
Want to see WOK full AI Analyst Report?

WORK Medical Technology Group LTD (WOK) Ratios

226 Followers

WORK Medical Technology Group LTD Ratios

WOK's free cash flow for Q2 2026 was $0.10. For the 2026 fiscal year, WOK's free cash flow was decreased by $ and operating cash flow was $-0.65. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
1.37 1.71 1.03 1.17 1.17
Quick Ratio
0.82 1.40 0.87 0.93 0.86
Cash Ratio
0.21 0.34 0.32 0.08 0.05
Solvency Ratio
-0.22 -0.01 -0.10 0.09 0.29
Operating Cash Flow Ratio
-0.05 0.52 -0.11 0.12 -0.16
Short-Term Operating Cash Flow Coverage
-0.13 0.97 -0.17 0.25 -0.36
Net Current Asset Value
$ 5.76M$ 8.46M$ 647.03K$ 3.18M$ 2.26M
Leverage Ratios
Debt-to-Assets Ratio
0.14 0.19 0.37 0.30 0.25
Debt-to-Equity Ratio
0.22 0.35 1.02 0.92 0.63
Debt-to-Capital Ratio
0.18 0.26 0.51 0.48 0.39
Long-Term Debt-to-Capital Ratio
0.00 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
1.60 1.81 2.75 3.03 2.55
Debt Service Coverage Ratio
-0.49 0.03 -0.11 0.22 0.69
Interest Coverage Ratio
-13.35 -4.96 -6.63 1.32 5.20
Debt to Market Cap
1.54 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
403.42 23.99 108.63 65.26 45.88
Net Debt to EBITDA
-1.06 6.95 -4.03 3.60 1.18
Profitability Margins
Gross Profit Margin
12.25%23.81%24.93%30.54%22.42%
EBIT Margin
-39.94%-5.87%-27.01%3.52%7.43%
EBITDA Margin
-29.76%3.45%-14.90%15.34%23.96%
Operating Profit Margin
-41.68%-25.34%-32.14%3.59%9.26%
Pretax Profit Margin
-41.26%-10.99%-31.86%0.81%5.65%
Net Profit Margin
-41.95%-10.89%-30.35%0.83%4.39%
Continuous Operations Profit Margin
-43.23%-12.19%-30.77%0.47%4.79%
Net Income Per EBT
101.68%99.14%95.27%101.49%77.70%
EBT Per EBIT
99.00%43.35%99.11%22.69%61.02%
Return on Assets (ROA)
-9.31%-3.23%-9.63%0.37%3.39%
Return on Equity (ROE)
-18.55%-5.85%-26.49%1.13%8.65%
Return on Capital Employed (ROCE)
-13.74%-11.78%-23.02%4.41%16.17%
Return on Invested Capital (ROIC)
-11.42%-9.04%-12.09%1.39%8.83%
Return on Tangible Assets
-9.49%-3.33%-9.92%0.39%3.52%
Earnings Yield
-14729.80%>-0.01%-0.05%<0.01%0.02%
Efficiency Ratios
Receivables Turnover
2.10 0.79 2.00 1.23 3.21
Payables Turnover
5.75 4.35 5.77 2.38 4.77
Inventory Turnover
1.09 2.04 2.71 2.04 3.51
Fixed Asset Turnover
0.64 0.93 0.81 2.01 2.47
Asset Turnover
0.22 0.30 0.32 0.45 0.77
Working Capital Turnover Ratio
1.50 2.16 5.94 4.86 24.87
Cash Conversion Cycle
444.09 556.70 253.81 321.07 141.44
Days of Sales Outstanding
174.06 461.41 182.53 295.57 113.86
Days of Inventory Outstanding
333.53 179.17 134.54 178.96 104.02
Days of Payables Outstanding
63.50 83.88 63.26 153.46 76.44
Operating Cycle
507.59 640.59 317.07 474.54 217.88
Cash Flow Ratios
Operating Cash Flow Per Share
-50.20 21.55 -17.26 15.24 -15.58
Free Cash Flow Per Share
-326.13 16.95 -88.97 11.22 -29.46
CapEx Per Share
275.93 4.60 71.71 4.02 13.88
Free Cash Flow to Operating Cash Flow
6.50 0.79 5.16 0.74 1.89
Dividend Paid and CapEx Coverage Ratio
-0.18 4.69 -0.24 3.79 -1.12
Capital Expenditure Coverage Ratio
-0.18 4.69 -0.24 3.79 -1.12
Operating Cash Flow Coverage Ratio
-0.13 0.97 -0.17 0.24 -0.36
Operating Cash Flow to Sales Ratio
-0.08 0.63 -0.19 0.16 -0.11
Free Cash Flow Yield
-131.40%0.02%-0.17%0.03%-0.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -2.02K -1.90K 46.59K 6.03K
Price-to-Sales (P/S) Ratio
0.40 2.20K 576.71 384.79 264.82
Price-to-Book (P/B) Ratio
<0.01 1.18K 503.26 528.54 521.96
Price-to-Free Cash Flow (P/FCF) Ratio
-0.76 4.42K -577.72 3.21K -1.22K
Price-to-Operating Cash Flow Ratio
-0.04 3.48K -2.98K 2.36K -2.31K
Price-to-Earnings Growth (PEG) Ratio
<0.01 -54.59 0.53 -534.94 -70.61
Price-to-Fair Value
<0.01 1.18K 503.26 528.54 521.96
Enterprise Value Multiple
-2.40 63.97K -3.87K 2.51K 1.11K
Enterprise Value
7.65M 21.71B 6.64B 5.23B 5.23B
EV to EBITDA
-2.40 63.97K -3.87K 2.51K 1.11K
EV to Sales
0.71 2.20K 577.31 385.34 265.11
EV to Free Cash Flow
-1.36 4.42K -578.32 3.21K -1.22K
EV to Operating Cash Flow
-8.84 3.48K -2.98K 2.37K -2.31K
Tangible Book Value Per Share
1.83K 69.74 116.39 68.88 70.63
Shareholders’ Equity Per Share
1.75K 63.30 102.14 68.11 68.97
Tax and Other Ratios
Effective Tax Rate
-0.05 -0.11 0.03 0.43 0.15
Revenue Per Share
621.47 33.98 89.13 93.56 135.94
Net Income Per Share
-260.72 -3.70 -27.05 0.77 5.97
Tax Burden
1.02 0.99 0.95 1.01 0.78
Interest Burden
1.03 1.87 1.18 0.23 0.76
Research & Development to Revenue
0.03 0.04 0.03 0.02 <0.01
SG&A to Revenue
0.51 0.45 0.57 0.14 0.13
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.19 -5.82 0.64 34.86 -2.39
Currency in USD